Proteome-based pathology: the next frontier in precision medicine

Expert Rev Precis Med Drug Dev. 2021;6(1):1-4. doi: 10.1080/23808993.2021.1854611.

Authors

Michael H Roehrl^{1

2}, Victor B Roehrl³, Julia Y Wang³

Affiliations

¹ Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY.
² Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY.
³ Curandis, New York, NY.

No abstract available

Keywords: autoimmunity; cancer; clinical trial; diagnostics; drug development; mass spectrometry; pathology; precision medicine; proteomics.

Grants and funding